Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights

Eslami, 2021, Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders, Diabet Med, 38, 10.1111/dme.14415 Mukhtar, 2020, A modern overview on diabetes mellitus: a chronic endocrine disorder, European J Biol, 5, 1, 10.47672/ejb.409 Kashyap, 2021, Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach, Environ Sci Pollut Res Int, 28, 35429, 10.1007/s11356-021-14480-7 da Cruz Freire, 2022, Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics, 3 Biotech, 12, 344, 10.1007/s13205-022-03406-w Razavi, 2022, DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits, Military Med Res, 9, 45, 10.1186/s40779-022-00410-2 Du, 2020, The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients, J Cell Mol Med, 24, 10274, 10.1111/jcmm.15674 Shao, 2020, Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions, Pharmacol Ther, 209, 10.1016/j.pharmthera.2020.107503 Fisman, 2021, The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect, Cardiovasc Diabetol, 20, 225, 10.1186/s12933-021-01412-5 Chow, 2022, The emerging role of incretins and twincretins, Nat Rev Endocrinol, 18, 73, 10.1038/s41574-021-00607-w Smit, 2021, Investigating GIPR (ant)agonism: a structural analysis of GIP and its receptor, Structure, 29, 679, 10.1016/j.str.2021.04.001 Hölscher, 2022, Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders, Br J Pharmacol, 179, 695, 10.1111/bph.15508 Paudel, 2021, In vitro and in silico characterization of G-protein coupled receptor (GPCR) targets of phlorofucofuroeckol-a and dieckol, Mar Drugs, 19, 326, 10.3390/md19060326 Ye, 2021, Two methods for the preparation of sitagliptin phosphate via chemical resolution and asymmetric hydrogenation, RSC Adv, 11, 4805, 10.1039/D0RA10273C Kareemulla, 2021, Safety and tolerability of vildagliptin in clinical practice: newer promising gliptin for type 2 diabetes mellitus, Int J Pharmaceut Biol Sci Archive, 9 Bae, 2022, Effects of teneligliptin on HbA1c levels, continuous glucose monitoring-derived time in range and glycemic variability in elderly patients with T2DM (TEDDY study), Diabetes Metab J, 46, 81, 10.4093/dmj.2021.0016 Mei, 2020, Applications of fluorine-containing amino acids for drug design, Eur J Med Chem, 186, 10.1016/j.ejmech.2019.111826 Sova, 2020, Efficient and straightforward syntheses of two United States pharmacopeia sitagliptin impurities: 3-desamino-2,3-dehydrositagliptin and 3-desamino-3,4-dehydrositagliptin, ACS Omega, 5, 5356, 10.1021/acsomega.9b04393 Burley, 2019, RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy, Nucleic Acids Res, 47, D464, 10.1093/nar/gky1004 Sigrist, 2013, New and continuing developments at PROSITE, Nucleic Acids Res, 41, D344, 10.1093/nar/gks1067 Lu, 2020, CDD/SPARCLE: the conserved domain database in 2020, Nucleic Acids Res, 48, D265, 10.1093/nar/gkz991 Blum, 2021, The InterPro protein families and domains database: 20 years on, Nucleic Acids Res, 49, D344, 10.1093/nar/gkaa977 Rocha, 2020, Novos insights sobre as propriedades físico-químicas do transportador de monoaminas VMAT2 humano e seu modo de interação com o neurotransmissor serotonina: Uma análise in silico, Res, Soc Dev, 9 Oliveira, 2020, Modelagem Estrutural de uma Quitinase (GH19) de Melão e Análise de Docking Molecular com N-Acetil-β(1-4)-D-Glicosamina, Revista Arquivos Científicos (IMMES), 3, 162, 10.5935/2595-4407/rac.immes.v3n1p162-171 Freire, 2021, New insights about the EptA protein and its correlation with the pmrC gene in polymyxin resistance in Pseudomonas aeruginosa, Curr Res Microb Sci, 2 Mendez, 2019, ChEMBL: towards direct deposition of bioassay data, Nucleic Acids Res, 47, D930, 10.1093/nar/gky1075 Eberhardt, 2021, AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings, J Chem Inf Model, 61, 3891, 10.1021/acs.jcim.1c00203 Schöning-Stierand, 2020, ProteinsPlus: interactive analysis of protein-ligand binding interfaces, Nucleic Acids Res, 48, W48, 10.1093/nar/gkaa235 Adasme, 2021, PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA, Nucleic Acids Res, 49, 10.1093/nar/gkab294 Huang, 2019, Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV, Sci Rep, 9 Asfour, 2021, Sitagliptin combined HIV-TAT as potential therapeutic targeting of SARS-CoV-2 virus, Int J Pharmacol, 18, 70, 10.3923/ijp.2022.70.78 Alhakamy, 2021, Evaluation of the antiviral activity of sitagliptin-glatiramer acetate nano-conjugates against SARS-CoV-2 virus, Pharmaceuticals, 14, 178, 10.3390/ph14030178 Varin, 2019, Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition, Cell Metabol, 29, 320, 10.1016/j.cmet.2018.10.001 Tian, 2010, Reversal of new-onset diabetes through modulating inflammation and stimulating β-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor, Endocrinology, 151, 3049, 10.1210/en.2010-0068 Pinheiro, 2016, Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3, Endocrinol Diabetes Metab Case Rep, 2016, 1 Istrate, 2022, Natural compounds as DPP-4 inhibitors: 3D-similarity search, ADME toxicity, and molecular docking approaches, Symmetry, 14, 1842, 10.3390/sym14091842 Khan, 2022, Evaluation of terpenoids as dipeptidyl peptidase 4 lead molecules: molecular docking and dynamics simulation study, Biointerface Res Appl Chem, 13, 376, 10.33263/BRIAC134.376 Subhani, 2020, In silico discovery of potential inhibitors against Dipeptidyl Peptidase-4: a major biological target of Type-2 diabetes mellitus, Int J Clin Microbiol Biochem Technol, 3 Shaikh, 2022, Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: an in silico and invitro study, Front Mol Biosci, 9, 10.3389/fmolb.2022.1024764 Cian, 2022, Identification and in silico study of a novel dipeptidyl peptidase IV inhibitory peptide derived from green seaweed Ulva spp. hydrolysates, LWT, 154, 10.1016/j.lwt.2021.112738 Nisha, 2017, Molecular docking analysis of potential dipeptidyl peptidase - 4 (DPP-4) inhibitors from Siddha formulation Pungampoo chooranam for treating diabetes mellitus, Int J Adv Res Biol Sci, 4, 78, 10.22192/ijarbs.2017.04.10.011